Cover Image
市場調查報告書

病毒性呼吸道感染疾病:全球臨床實驗檢討

Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 239392
出版日期 內容資訊 英文 40 Pages
訂單完成後即時交付
價格
Back to Top
病毒性呼吸道感染疾病:全球臨床實驗檢討 Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015
出版日期: 2015年11月25日 內容資訊: 英文 40 Pages
簡介

本報告提供全球病毒性呼吸道感染疾病治療藥物臨床實驗的相關調查,提供不同地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各種贊助企業臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

  • 簡介
  • 病毒性呼吸道感染疾病
  • 報告指南
  • 臨床實驗:各地區
  • 臨床實驗:各國
  • - 亞太地區實施臨床實驗的主要5個國家
  • - 歐洲實施臨床實驗的主要5個國家
  • 實施臨床實驗的主要國 - 北美
  • 實施臨床實驗的主要國 - 中東及非洲
  • - 中南美實施臨床實驗的主要5個國家
  • 金磚四國的臨床實驗
  • G7各國的臨床實驗
  • 臨床G7各國的臨床實驗:各臨床實驗狀態
  • E7各國的臨床實驗
  • 臨床E7各國的臨床實驗:各臨床實驗狀態
  • 各方面臨床實驗
  • 進行中的臨床實驗:各階段
  • 臨床實驗:各臨床實驗狀態
  • 未完成的臨床實驗
  • 每段時期的實驗人數
  • 有力的贊助商
  • 主要的參與臨床實驗企業
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 主要企業臨床實驗概要
    • Baxter Deutschland GmbH
    • Sanofi
    • Qiagen N.V.
  • 主要研究機關·政府機關的臨床實驗概要
    • St. Jude Children's Research Hospital, Inc.
    • Queen's University
    • Assistance Publique - Hopitaux de Paris
    • The University of New South Wales
    • University of Maribor
    • The Children's Hospital at Westmead
    • Queen Mary Hospital
    • Winthrop-University Hospital
    • Oulu University Hospital
    • Hospital Sirio-Libanes
    • Menzies School of Health Research
    • Medical Research Council
    • Princess Margaret Hospital
    • The National Institute of Allergy and Infectious Diseases
    • National Institute of Infectious Diseases
    • Indian Council of Medical Research
  • 5個主要的臨床簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2979CTIDB

GlobalData's clinical trial report, "Viral Respiratory Tract Infection Global Clinical Trials Review, H2, 2015" provides an overview of Viral Respiratory Tract Infection clinical trials scenario. This report provides top line data relating to the clinical trials on Viral Respiratory Tract Infection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials by E7 Countries: Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Viral Respiratory Tract Infection Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Region, 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials, G7 Countries (%), 2015*
  • Viral Respiratory Tract Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials, E7 Countries (%), 2015*
  • Viral Respiratory Tract Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Viral Respiratory Tract Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Viral Respiratory Tract Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*

List of Figures

  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials, G7 Countries (%), 2015*
  • Viral Respiratory Tract Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Proportion of Viral Respiratory Tract Infection to Respiratory Clinical Trials, E7 Countries (%), 2015*
  • Viral Respiratory Tract Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Viral Respiratory Tract Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Viral Respiratory Tract Infection Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Viral Respiratory Tract Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Viral Respiratory Tract Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top